Heart, Lung and Circulation
Volume 15, Issue 1 , Pages 3-11, February 2006

ICD Therapy: What Have We Learned From the Clinical Trials?

Department of Pacemaker and Electrophysiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Mellat Park, Vali-e-Asr Avenue, Tehran 1996911151, Iran

Development of implantable cardioverter defibrillators (ICD) has been a dramatic advancement in the management of patients with life-threatening ventricular arrhythmias. We hereby reviewed the landmark clinical trials on ICD with special emphasis on late-breaking clinical trials and assessed their impact on every-day decision making and patient selection for ICD implantation.

Keywords: Implantable cardioverter hdefibrillator, Primary prevention, Ventricular arrhythmia, Clinical trial, Cardiac resynchronization, Sudden cardiac death

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1443-9506(05)00151-4

doi:10.1016/j.hlc.2005.08.002

Heart, Lung and Circulation
Volume 15, Issue 1 , Pages 3-11, February 2006

Article Tools

* Image Usage & Resolution